GR3035613T3 - Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids - Google Patents
Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acidsInfo
- Publication number
- GR3035613T3 GR3035613T3 GR20010400459T GR20010400459T GR3035613T3 GR 3035613 T3 GR3035613 T3 GR 3035613T3 GR 20010400459 T GR20010400459 T GR 20010400459T GR 20010400459 T GR20010400459 T GR 20010400459T GR 3035613 T3 GR3035613 T3 GR 3035613T3
- Authority
- GR
- Greece
- Prior art keywords
- formulations
- compounds
- fatty acids
- digestible oils
- nanoparticulate dispersions
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/384,057 US5571536A (en) | 1995-02-06 | 1995-02-06 | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
| US08/388,088 US5560931A (en) | 1995-02-14 | 1995-02-14 | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
| PCT/US1996/001433 WO1996024332A1 (en) | 1995-02-06 | 1996-01-31 | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3035613T3 true GR3035613T3 (en) | 2001-06-29 |
Family
ID=27010448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20010400459T GR3035613T3 (en) | 1995-02-06 | 2001-03-20 | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0808154B1 (el) |
| JP (1) | JPH10513200A (el) |
| AT (1) | ATE198148T1 (el) |
| AU (1) | AU4862796A (el) |
| CA (1) | CA2207304A1 (el) |
| DE (1) | DE69611287T2 (el) |
| DK (1) | DK0808154T3 (el) |
| ES (1) | ES2154806T3 (el) |
| GR (1) | GR3035613T3 (el) |
| PT (1) | PT808154E (el) |
| WO (1) | WO1996024332A1 (el) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1009856A5 (fr) | 1995-07-14 | 1997-10-07 | Sandoz Sa | Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule. |
| US6045829A (en) * | 1997-02-13 | 2000-04-04 | Elan Pharma International Limited | Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers |
| ES2257041T3 (es) * | 1998-03-30 | 2006-07-16 | Jagotec Ag | Composicion y metodo para preparar microparticulas de substancias insolubles en agua. |
| US6337092B1 (en) | 1998-03-30 | 2002-01-08 | Rtp Pharma Inc. | Composition and method of preparing microparticles of water-insoluble substances |
| US8067032B2 (en) | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
| US9700866B2 (en) | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
| US20050048126A1 (en) | 2000-12-22 | 2005-03-03 | Barrett Rabinow | Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
| US7037528B2 (en) | 2000-12-22 | 2006-05-02 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
| CA2461349C (en) | 2001-09-26 | 2011-11-29 | Baxter International Inc. | Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal |
| US20060003012A9 (en) | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
| US8722736B2 (en) | 2007-05-22 | 2014-05-13 | Baxter International Inc. | Multi-dose concentrate esmolol with benzyl alcohol |
| US8426467B2 (en) | 2007-05-22 | 2013-04-23 | Baxter International Inc. | Colored esmolol concentrate |
| BRPI0917771A2 (pt) * | 2008-12-18 | 2015-08-04 | Basf Se | Dispersão aquosa, metodo de preparo da disperção, composição sólida, uso de um anfifílico, uso da dispersão e semente |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2714065A1 (de) * | 1977-03-30 | 1978-10-12 | Boehringer Mannheim Gmbh | Instillationszubereitung |
| DE3623376A1 (de) * | 1986-07-11 | 1988-01-21 | Behringwerke Ag | Pharmazeutische formulierung und verfahren zu deren herstellung |
| IL88076A (en) * | 1987-10-28 | 1993-01-14 | Nippon Shinyaku Co Ltd | Fat emulsions as drug carriers |
| GB8822857D0 (en) * | 1988-09-29 | 1988-11-02 | Patralan Ltd | Pharmaceutical formulations |
| GB9022788D0 (en) * | 1990-10-19 | 1990-12-05 | Cortecs Ltd | Pharmaceutical formulations |
| US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| GB9300875D0 (en) * | 1993-01-18 | 1993-03-10 | Ucb Sa | Nanocapsule containing pharmaceutical compositions |
-
1996
- 1996-01-31 WO PCT/US1996/001433 patent/WO1996024332A1/en active IP Right Grant
- 1996-01-31 AU AU48627/96A patent/AU4862796A/en not_active Abandoned
- 1996-01-31 PT PT96904552T patent/PT808154E/pt unknown
- 1996-01-31 ES ES96904552T patent/ES2154806T3/es not_active Expired - Lifetime
- 1996-01-31 EP EP96904552A patent/EP0808154B1/en not_active Expired - Lifetime
- 1996-01-31 DE DE69611287T patent/DE69611287T2/de not_active Expired - Fee Related
- 1996-01-31 CA CA002207304A patent/CA2207304A1/en not_active Abandoned
- 1996-01-31 AT AT96904552T patent/ATE198148T1/de not_active IP Right Cessation
- 1996-01-31 DK DK96904552T patent/DK0808154T3/da active
- 1996-01-31 JP JP8524341A patent/JPH10513200A/ja not_active Ceased
-
2001
- 2001-03-20 GR GR20010400459T patent/GR3035613T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69611287T2 (de) | 2001-08-09 |
| EP0808154A1 (en) | 1997-11-26 |
| JPH10513200A (ja) | 1998-12-15 |
| CA2207304A1 (en) | 1996-08-15 |
| PT808154E (pt) | 2001-06-29 |
| WO1996024332A1 (en) | 1996-08-15 |
| ES2154806T3 (es) | 2001-04-16 |
| ATE198148T1 (de) | 2001-01-15 |
| DE69611287D1 (de) | 2001-01-25 |
| DK0808154T3 (da) | 2001-04-30 |
| EP0808154B1 (en) | 2000-12-20 |
| AU4862796A (en) | 1996-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1032363B1 (en) | Conjugated linoleic acid delivery system in cosmetic preparations | |
| TW429145B (en) | Pharmaceutical composition for treating schizophrenia, tardive dyskinesia, depression, and alzheimer's disease comprising EPA/SA | |
| GR3035613T3 (en) | Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids | |
| MY136927A (en) | Highly purified ethyl epa and other epa derivatives for neurological disorders | |
| NZ504076A (en) | A topical formulation which induces a minimal systemic effect when applied to the skin, the topical formulation comprising an immunosuppressive macrolide selected from sirolimus, FK506 and SDZ ASM 981 and a permeation modulator for the treatment of a dermatological condition | |
| KR940018091A (ko) | 불포화 지방산을 포함하는 처방 | |
| EP1787532A3 (en) | Microbial oil mixtures and uses thereof | |
| DK0904064T3 (da) | Orale farmaceutiske præparater indeholdende kønshormoner | |
| IE910050A1 (en) | EFA compositions and therapy | |
| GB9907715D0 (en) | Pharmaceutical compositions | |
| EP1072246A3 (de) | Kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen | |
| AU6843000A (en) | High lipid diet | |
| ZA971134B (en) | Multifunctional fat absorption and blood cholesterol reducing formulation. | |
| DE60106406D1 (de) | Zubereitungen zur anwendung als penetrationförderer in transdermalen arzneimitteln die hoch-lipophile wirkstoffe enthalten | |
| HK1037126A1 (en) | Compositions for the treatment of acne. | |
| ATE110274T1 (de) | Mittel zur verbesserung spezifischer eigenschaften des blutes. | |
| AP2002002384A0 (en) | Parenteral cisplatin emulsion | |
| IL128843A0 (en) | Formulations for topical use | |
| WO1999039682A3 (en) | Lipid mixtures and their use | |
| AU8740198A (en) | Inhibitor and preservative formulation | |
| HUP0000419A2 (hu) | Eikozapentaénsavat és/vagy sztearidonsavat tartalmazó gyógyászati készítmény | |
| BG104029U (en) | Formulation for the treatment of dermatozoonoses | |
| MY129218A (en) | Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ML | Lapse due to non-payment of fees |